Eric Peterson has been named executive vice president of BioVentures LLC, the technology licensing office and business incubator at UAMS.
Peterson is chair of the UAMS Patent and Copyright Committee and is an associate professor in the College of Medicine Department of Pharmacology and Toxicology. His primary research focus has been the design of antibody nanotechnology and gene therapy technologies that could reduce or block the rewarding effects of methamphetamine use disorder. Peterson is listed as an inventor on three patents for his contributions to immunotherapies for drug use disorder treatment.
As executive vice president at BioVentures, he'll oversee technology development in collaboration and partnership with the University of Arkansas.
“Dr. Peterson has unique expertise in technology development and has already streamlined some of our processes, so we’re really excited to have him in this expanded leadership role,” Dr. Kevin Sexton, president of BioVentures, said in a news release.